Former PerkinElmer Executive Joins Moderna As Finance Chief

Moderna Inc MRNA appointed James Mock as its Chief Financial Officer, beginning September 6, 2022.
In May, Moderna's newly appointed Chief Financial Officer, Jorge Gomez, departed the company immediately after joining office a day before.
The announcement follows the public disclosure by Gomez's former employer, Dentsply Sirona Inc XRAY, of an ongoing internal investigation into some issues, including financial reporting.
Related Content: Moderna Justifies It Did Not Know About Investigation On Its New CFO.
Following the appointment of Mr. Mock, David Meline will retire as the company's CFO effective the same date but will remain a consultant to the company to assist with the transition.
Before joining Moderna, Mr. Mock served as Senior Vice President and CFO of PerkinElmer Inc PKI.
Price Action: MRNA shares are down 5.26% at $159.13 during the market session on the last check Wednesday.
Photo via Wikimedia Commons